Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
ASH 2016 - Multiple Myeloma
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Findings from the Connect MM Registry: Changes in Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Carfilzomib, Pomalidomide, and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Elotuzumab, Lenalidomide, and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Response-Adapted Therapy for Newly Diagnosed Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Treatment with a Novel HDAC6 Inhibitor plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Sustained Overall Survival in Patients with Smoldering Myeloma Receiving Lenalidomide-Based Therapy
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance: Data from the Connect MM Disease Registry
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Ixazomib, Pomalidomide, and Dexamethasone Triplet Therapy in Patients with Double/Triple Refractory Myeloma
Read More
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Evaluation of Minimal Residual Disease in Relapsed/Refractory Multiple Myeloma Patients Treated with a Daratumumab-Based Regimen
Read More
1
2
Page 1 of 2
Results 1 - 10 of 19